Merck Receivables 2010-2024 | MKKGY
Merck receivables from 2010 to 2024. Receivables can be defined as the total amount of collectibles for a company
- Merck receivables for the quarter ending June 30, 2024 were $5.085B, a 1.18% decline year-over-year.
- Merck receivables for 2023 were $4.845B, a 0.85% increase from 2022.
- Merck receivables for 2022 were $4.804B, a 1.86% decline from 2021.
- Merck receivables for 2021 were $4.896B, a 14.56% increase from 2020.
Merck Annual Receivables
(Millions of US $) |
| 2023 |
$4,845 |
| 2022 |
$4,804 |
| 2021 |
$4,896 |
| 2020 |
$4,273 |
| 2019 |
$4,566 |
| 2018 |
$4,005 |
| 2017 |
$3,858 |
| 2016 |
$3,643 |
| 2015 |
$3,473 |
| 2014 |
$2,972 |
| 2013 |
$2,831 |
| 2012 |
$2,720 |
| 2011 |
$3,243 |
| 2010 |
$ |
| 2009 |
$ |
Merck Quarterly Receivables
(Millions of US $) |
| 2024-06-30 |
$5,085 |
| 2024-03-31 |
$4,975 |
| 2023-12-31 |
$4,845 |
| 2023-09-30 |
$5,169 |
| 2023-06-30 |
$5,146 |
| 2023-03-31 |
$5,036 |
| 2022-12-31 |
$4,804 |
| 2022-09-30 |
$4,693 |
| 2022-06-30 |
$5,013 |
| 2022-03-31 |
$5,048 |
| 2021-12-31 |
$4,896 |
| 2021-09-30 |
$4,752 |
| 2021-06-30 |
$4,832 |
| 2021-03-31 |
$4,900 |
| 2020-12-31 |
$4,273 |
| 2020-09-30 |
$4,667 |
| 2020-06-30 |
$4,368 |
| 2020-03-31 |
$4,767 |
| 2019-12-31 |
$4,566 |
| 2019-09-30 |
$4,187 |
| 2019-06-30 |
$4,240 |
| 2019-03-31 |
$4,594 |
| 2018-12-31 |
$4,005 |
| 2018-09-30 |
$3,900 |
| 2018-06-30 |
$4,111 |
| 2018-03-31 |
$4,346 |
| 2017-12-31 |
$3,858 |
| 2017-09-30 |
$3,840 |
| 2017-06-30 |
$3,739 |
| 2017-03-31 |
$3,781 |
| 2016-12-31 |
$3,643 |
| 2016-09-30 |
$3,524 |
| 2016-06-30 |
$3,663 |
| 2016-03-31 |
$3,523 |
| 2015-12-31 |
$3,473 |
| 2015-09-30 |
$3,068 |
| 2015-06-30 |
$3,090 |
| 2015-03-31 |
$3,220 |
| 2014-12-31 |
$2,972 |
| 2014-09-30 |
$3,010 |
| 2014-06-30 |
$3,233 |
| 2014-03-31 |
$2,924 |
| 2013-12-31 |
$2,831 |
| 2013-09-30 |
$2,834 |
| 2013-06-30 |
$2,990 |
| 2013-03-31 |
$3,086 |
| 2012-12-31 |
$2,720 |
| 2012-09-30 |
$2,761 |
| 2012-06-30 |
$2,936 |
| 2012-03-31 |
|
| 2011-12-31 |
$3,243 |
| 2011-09-30 |
|
| 2011-06-30 |
$3,319 |
| 2011-03-31 |
|
| 2010-12-31 |
|
| 2010-09-30 |
$2,912 |
| 2010-06-30 |
|
| 2010-03-31 |
|
| 2009-12-31 |
|
| 2009-09-30 |
|
| 2009-06-30 |
|
| 2009-03-31 |
|
| Sector |
Industry |
Market Cap |
Revenue |
| Medical |
MED-DRUGS |
$21.306B |
$22.719B |
|
Merck is a global pharmaceutical and chemical company. Its success is characterized by innovations from entrepreneurial employees. Merck's operating activities come under the umbrella of Merck KGaA, in which the Merck family holds an approximately 70% interest and free shareholders own the remaining approximately 30%. In 1917 the U.S. subsidiary Merck & Co. was expropriated and has been an independent company ever since.
|
